Colin Love

Equibles does not estimate personal net worth.

About Colin Love

Earlier roles on record: COO at Replimune Group, Inc. (REPL) until May 31, 2024. Replimune Group, Inc. reported in an 8-K filed March 26, 2024 that Colin Love retired as chief operating officer, effective May 31, 2024.

“Dr. Colin Love, the Company's current chief operating officer, will retire from the Company, effective May 31, 2024”

Replimune Group, Inc. Form 8-K, filed March 26, 2024 · Read the filing

Affiliation history

Replimune Group, Inc. (REPL)
COO

Proxy statement

Start not stated–2024-05-31

Company network

Replimune Group, Inc.

REPL

Biotechnology · Healthcare

COO

Recent activity

Executive change Retired: chief operating officer Replimune Group, Inc. (REPL)
2024-05-31